RCUS

Arcus Biosciences, Inc.

Healthcare›Biotechnology|New York Stock Exchange|US

Price

$22.96

Market Cap

$2.31B

Beta

0.86

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-4.26%

EPS Growth (YoY)-5.80%

Revenue CAGR 3Y+30.30%

P/E Ratio0.0

PEG Ratio—

FCF Yield-20.94%

Debt / Equity0.16

Interest Coverage-19.3x

No credit card required

Already have an account? Sign in to view the full analysis for RCUS.